7 Signs of Counterfeit Weight-Loss Jabs and Their Health Risks
A recent survey by the National Pharmacy Association (NPA) reveals that criminals are increasingly exploiting the high demand for weight-loss injections by cloning legitimate online pharmacies to sell counterfeit drugs. The study found that approximately one in ten UK pharmacies had their online presence impersonated, while nearly 40% reported treating patients who unknowingly purchased fake medications. In response, obesity specialist pharmacist Sehar Shahid outlines seven critical red flags to help consumers identify illicit sellers. These warning signs include prices significantly below the market average, lack of mandatory medical consultations, requests for unconventional payment methods like bank transfers or cryptocurrency, and subtle discrepancies in website domain names. Additional indicators involve poor communication channels, cloudy or discolored liquid in injections, and unsealed or low-quality packaging. The NPA highlights that 95.2% of respondents are concerned about the severe health risks posed by these unregulated products. This analysis serves as a crucial public health advisory, urging patients to verify pharmacy registration with the General Pharmaceutical Council and remain vigilant against sophisticated online scams that compromise patient safety and clinical appropriateness.
Wire timeline
7 Signs of Counterfeit Weight-Loss Jabs and Their Health Risks
A recent survey by the National Pharmacy Association (NPA) reveals that criminals are increasingly exploiting the high demand for weight-loss injections by cloning legitimate online pharmacies to sell counterfeit drugs. The study found that approximately one in ten UK pharmacies had their online presence impersonated, while nearly 40% reported treating patients who unknowingly purchased fake medications. In response, obesity specialist pharmacist Sehar Shahid outlines seven critical red flags to help consumers identify illicit sellers. These warning signs include prices significantly below the market average, lack of mandatory medical consultations, requests for unconventional payment methods like bank transfers or cryptocurrency, and subtle discrepancies in website domain names. Additional indicators involve poor communication channels, cloudy or discolored liquid in injections, and unsealed or low-quality packaging. The NPA highlights that 95.2% of respondents are concerned about the severe health risks posed by these unregulated products. This analysis serves as a crucial public health advisory, urging patients to verify pharmacy registration with the General Pharmaceutical Council and remain vigilant against sophisticated online scams that compromise patient safety and clinical appropriateness.
independent